What matters this morning (ET)
- Equity futures point lower into a holiday-thinned tape. S&P 500 futures are indicated down modestly in early trading, with traders leaning cautious after Friday’s mixed close. (barrons.com)
- Earnings-driven dispersion stays the story. Big pre-market moves are concentrated in single names tied to results/guidance (RIVN, ROKU up; PINS down). (barrons.com)
- Rates are steady-to-higher around ~4.11% on 10s (per available public snapshot). That keeps duration-sensitive growth crowded and reactive to any rate impulse. (barrons.com)
- Crypto is bid. Bitcoin is up ~4% vs prior close, adding to risk appetite at the margin. (barrons.com)
- Treasury supply overhang is fading (refundings this week are done; settlement next week). The Feb refunding auctions (3Y/10Y/30Y) have already occurred; settlement is Tue, Feb 17, 2026. (home.treasury.gov)
- Moderna headlines add biotech noise. Moderna reported Q4/FY2025 results and disclosed an FDA refusal-to-file on its flu vaccine submission (seeking a Type A meeting). (sec.gov)
Pre-market table
| Section | Item | Latest | Move/Status | Interpretation | Source(s) |
|---|---|---|---|---|---|
| Market Overview | S&P 500 (ES) futures | Unavailable (CME page requires dynamic quote access in this environment) | Unavailable | Without a verifiable live ES quote, avoid inferring index-level risk tone beyond headline reports. | (cmegroup.com) |
| Market Overview | Nasdaq 100 (NQ) futures | Unavailable | Unavailable | Same constraint; keep focus on confirmed, source-backed movers. | (cmegroup.com) |
| Market Overview | Russell 2000 (RTY) futures | Unavailable | Unavailable | Small-cap tone can’t be validated via a live RTY print here. | (cmegroup.com) |
| Rates & Dollar | US 10Y yield | ~4.11% (most recently available public snapshot) | Mixed (exact live bps: Unavailable) | 10Y holding ~4.1% keeps equity multiples sensitive to any re-pricing in real yields. | (barrons.com) |
| Rates & Dollar | DXY | Unavailable | Unavailable | Dollar impulse can’t be confirmed from an accessible live ICE/DXY quote here. | (ice.com) |
| Commodities | WTI (front-month) | Unavailable | Unavailable | No verifiable live WTI quote captured; skip macro read-through. | (cmegroup.com) |
| Commodities | Gold | $4,943.10/oz (as of timestamp shown on source page) | +0.08% (per source) | Elevated gold supports a “hedges still in demand” undertone. | (bullion.com) |
| Crypto | Bitcoin | $69,621 | +4.04% vs prior close | Crypto strength can buoy high-beta sentiment, but confirm follow-through in US cash hours. | |
| Notable Movers | RIVN | Unavailable (price) | +20.4% pre-mkt | Sharp upside suggests a catalyst-driven repricing; treat as idiosyncratic until broader confirmation. | (barrons.com) |
| Notable Movers | ROKU | Unavailable (price) | +15.3% pre-mkt | Big premarket gap implies guidance/earnings surprise is driving risk-on in the name. | (barrons.com) |
| Notable Movers | PINS | Unavailable (price) | -20.8% pre-mkt | A drawdown of this magnitude typically reflects guidance reset; watch sector sympathy in ad-tech. | (barrons.com) |
| Notable Movers | BIO (Bio-Rad) | Unavailable (price) | -13.5% pre-mkt | Indicates a negative earnings/guidance read-through; could pressure adjacent med-tech/tools. | (barrons.com) |
| Notable Movers | MRNA | Earnings release filed/exhibited | Reported Q4 rev $678m; GAAP EPS -$2.11 (per release) | Results + FDA “refusal-to-file” disclosure can widen biotech dispersion and headline risk. | (sec.gov) |
| Earnings Today | US earnings calendar (pre / post) | Unavailable | Unavailable | No accessible, non-gated authoritative earnings calendar captured in this run; avoid listing. | Unavailable |
| Macro / Policy Calendar | Fed speakers (official Fed calendar) | Unavailable for Feb 14 specifics (calendar is JS-gated; partial list only) | Unavailable | Without a verifiable day-specific schedule, don’t assume speaker risk. | (federalreserve.gov) |
| Macro / Policy Calendar | Treasury auctions | No new coupon auctions listed for today; Feb refunding auctions already held; settle Tue Feb 17 | Completed | Supply event risk is reduced; settlement can still affect funding/positioning. | (home.treasury.gov) |
| Analyst Actions | Key upgrades/downgrades | Unavailable | Unavailable | No verifiable, non-paywalled analyst-action feed captured; skip. | Unavailable |
| Extraordinary International | China/ADR-linked developments | Unavailable | Unavailable | No verified China/ADR market-moving development captured in the past 24h sources fetched. | Unavailable |
Risks to today’s setup (ET)
- Liquidity/positioning risk around a long weekend (President’s Day closure Monday) can amplify gaps and reversals. (investors.com)
- Earnings headline risk remains high given the large pre-market gaps in several single names. (barrons.com)
- Rates sensitivity: any move away from ~4.1% in 10Y yields could quickly reprice growth multiples. (barrons.com)
Data timestamp: Feb 14, 2026, 5:40 AM ET (system time at data pull); market/asset snapshots reflect the latest timestamps available in cited sources at fetch time.